| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K29313308 |
| PharmacoGx | BRD-K29313308 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDPD2 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | NUP210 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | SRCAP | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | FBRSL1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | OTOA | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | DOT1L | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-06 |
| mRNA | C1orf68 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | SEPT10 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-06 |
| mRNA | CAPN15 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
